Ultima Vez Modificado: 22 de noviembre del 2006
On-demand webcast from The "Opportunities in Proton Therapy" symposium held November 7, 2006. Worldwide cancer experts give you a unique opportunity to discover and share the information on the latest developments in Proton Therapy including dose distribution comparisons and anticipated gains, detailed clinical applications and trends in Proton Therapy care. Experience the collected knowledge of Nancy Mendenhall, MD and Tom DeLaney, MD as well as a host of other thought leaders in the exciting field of Proton Therapy.
You will need to use Internet Explorer to view this webcast.
Jan 26, 2015 - Long-term survival may be increased in medium-risk prostate cancer patients who receive short-term androgen deprivation therapy before and during radiation treatment compared with men who receive radiation alone. In addition, proton beam therapy may be associated with a decreased risk of disease recurrence after 10 years and has minimal side effects after one year, according to research presented at the 51st Annual Meeting of the American Society for Radiation Oncology, held from Nov. 1 to 5 in Chicago.
Apr 18, 2012
Nov 12, 2010
May 24, 2011